7 minute read

Jul. 17, 2024

Targeting Post-Transcriptional RNA-Modification with a First-to-Clinic METTL3 Inhibitor: STC15

Author:

Shaima Qunies

Reviewer:

Editors:

Dennis X. Hu,

Rory McAtee

Other articles you may be interested in